Growth Metrics

Vertex Pharmaceuticals (VRTX) EBT Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 441.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,297.00
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 441.00
Dec 31, 2025 -504.00
Sep 30, 2025 -818.00
Jun 30, 2025 -337.00
Mar 31, 2025 -1,915.00
Dec 31, 2024 -299.00
Sep 30, 2024 -1,041.00
Jun 30, 2024 -12,572.00
Mar 31, 2024 -7.00
Dec 31, 2023 -901.00
Sep 30, 2023 -101.00
Jun 30, 2023 -751.00
Mar 31, 2023 -586.00
Dec 31, 2022 -38,774.00
Sep 30, 2022 4,296.00
Jun 30, 2022 1,189.00
Mar 31, 2022 822.00
Dec 31, 2021 3,828.00
Sep 30, 2021 3,717.00
Jun 30, 2021 -3,126.00
Mar 31, 2021 1,411.00
Dec 31, 2020 3,733.00
Sep 30, 2020 12,064.00
Jun 30, 2020 4,758.00
Mar 31, 2020 793.00
Dec 31, 2019 43,007.00
Sep 30, 2019 1,697.00
Jun 30, 2019 3,899.00
Mar 31, 2019 4,499.00
Dec 31, 2018 2,244.00
Sep 30, 2018 4,797.00
Jun 30, 2018 14,372.00
Mar 31, 2018 18,509.00
Dec 31, 2017 14,080.00
Sep 30, 2017 4,935.00
Jun 30, 2017 13,602.00
Mar 31, 2017 23,075.00
Dec 31, 2016 1,962.00
Sep 30, 2016 4,410.00
Jun 30, 2016 1,688.00
Mar 31, 2016 12,441.00
Dec 31, 2015 548.00
Sep 30, 2015 -2,905.00
Jun 30, 2015 -11,148.00
Mar 31, 2015 -17,502.00
Dec 31, 2014 -16,097.00
Sep 30, 2014 -16,931.00
Mar 31, 2014 4,378.00
Dec 31, 2013 26,012.00
Sep 30, 2013 82,452.00
Jun 30, 2013 61,138.00
Mar 31, 2013 59,812.00
Dec 31, 2012 42,125.00
Sep 30, 2012 59,777.00
Jun 30, 2012 83,060.00
Mar 31, 2012 70,181.00